The following Management s Discussion and Analysis of Financial Condition and
Results of Operations relates to Encompass Health Corporation and its
subsidiaries and should be read in conjunction. | May 3, 2023
Differentiated Portfolio and Strong Execution Drives 1Q Sales and Earnings Growth
Increased 2023 Full-Year Guidance, Including Biologicals Acquisitions
Well Positioned to Deliver Attractive. | May 3, 2023
/PRNewswire/ Resideo Technologies, Inc. (NYSE: REZI), a leading global manufacturer and developer of technology-driven products and components that provide.